For many young college students, the first years are a time of wonder and excitement and early steps toward long-term goals. These years, for some students, are equally fraught with anxiety, as the realities of rigorous curricula set in alongside feelings of unpreparedness and impostor syndrome. In the STEM fields, this results in roughly 50%… Read More »
Major breakthrough in MMR vaccine research A new study has revealed a ground-breaking revelation that there is no link between autism and the MMR vaccine. Focus turns to NZ resettlement after medevac repealed 4:38 Long-term marijuana smoking associated with testicular cancer 1:18 Major breakthrough in MMR vaccine research 0:54 Two dead in Hawaii naval base… Read More »
Episerver continues to prove customer-centric focus with a customer-experience leader taking its top spot. London, UK, Dec. 4th, 2019 – Episerver™, the customer-centric digital experience company, has named Alex Atzberger as its CEO. Atzberger joins Episerver after spending nearly 15 years with SAP™ – one of the top-20 most valuable brands in the world –… Read More »
DigEplan, a leading integrated electronic plan review solution, and GIS-centric public asset management solution firm, Cityworks have worked to combine platforms, bringing Cityworks customers the powerful functionality of an integrated tool for electronic plan review. Announcing the joint venture at the Cityworks Conference in Salt Lake City, December 4 – 6th, Cityworks PLL (permits, licensing… Read More »
When Amgen signed an outcomes-based reimbursement deal for its blockbuster rheumatoid arthritis drug Enbrel with Harvard Pilgrim Healthcare in 2017, it seemed like a strategy for preserving the market share of a product on the cusp of losing its patent protection. The patent threat has since been pushed off several years—but Amgen is still making… Read More »